京新药业再度向港交所递交上市申请 中信证券独家保荐

观点地产网
Sep 21

观点网讯:9月18日,京新药业向港交所主板递交上市申请,中信证券为其独家保荐人。

京新药业是一家A股上市逾20年的制药企业,此次为其二度冲刺港股。此前其于2026年2月首次递表,后因6个月有效期届满而失效。

免责声明:本文内容与数据由观点根据公开信息整理,不构成投资建议,使用前请核实。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10